FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320492875> ?p ?o ?g. }

• W4320492875 endingPage "1320" @default.
• W4320492875 startingPage "1310" @default.
• W4320492875 abstract "Abstract Context A recent US national survey of the health status of the male transgender population has raised awareness about the little-studied relationship between testosterone hormone therapy in transgender men and cardiovascular outcomes. Objective The aim of this systematic review was to assess the relationship between cross-sex hormone therapy in transgender men and lipid profiles and cardiovascular risk. Data Sources The PubMed, SciELO, SpringerLink, and EBSCOhost databases were searched up to March 2021 for studies assessing the association between cross-sex hormone therapy and the incidence of outcomes related to cardiovascular disease in transgender men over 18 years of age . Data Extraction Data extracted were sorted into clinical data (systolic, diastolic, and mean blood pressure), anthropometric data (body mass index, weight, waist circumference, fat mass, and lean mass), and biochemical data (triglycerides, total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], very low-density lipoprotein cholesterol [VLDL-C], and the HDL-C to LDL-C ratio). Data Analysis Study quality was appraised independently by two reviewers using the Cochrane tools for assessment of methodological quality or risk of bias in nonrandomized studies, and the Newcastle-Ottawa Scale was applied. Of 735 studies identified, 11 were included in the review. Most studies reported no change in cholesterol or triglyceride levels after hormone treatment. A reduction in HDL-C levels was observed in 7 of 11 studies, although this alone cannot be considered a cardiovascular risk factor. Likewise, clinical and anthropometric findings showed no changes predictive of cardiovascular risk. Conclusions Although these findings suggest that hormone therapy may lead to a decrease in HDL-C levels and an increase in LDL-C levels, they are insufficient to establish a relationship with cardiovascular disease. Furthermore, no significant effects on metabolic and anthropometric values were found. Further studies with higher quality and longer follow-up periods are needed to establish cardiovascular risk. Systematic Review Registration PROSPERO registration number CRD 42020212560." @default.
• W4320492875 created "2023-02-14" @default.
• W4320492875 creator A5001617413 @default.
• W4320492875 creator A5008553361 @default.
• W4320492875 creator A5015189052 @default.
• W4320492875 creator A5032119928 @default.
• W4320492875 creator A5033278584 @default.
• W4320492875 creator A5035828050 @default.
• W4320492875 creator A5049699776 @default.
• W4320492875 creator A5052389403 @default.
• W4320492875 creator A5063521556 @default.
• W4320492875 creator A5065377981 @default.
• W4320492875 creator A5077736507 @default.
• W4320492875 date "2023-02-13" @default.
• W4320492875 modified "2023-09-28" @default.
• W4320492875 title "Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review" @default.
• W4320492875 cites W1572984760 @default.
• W4320492875 cites W1599141406 @default.
• W4320492875 cites W1953962102 @default.
• W4320492875 cites W1971312169 @default.
• W4320492875 cites W1981386872 @default.
• W4320492875 cites W2003749750 @default.
• W4320492875 cites W2024209187 @default.
• W4320492875 cites W2031672510 @default.
• W4320492875 cites W2055039921 @default.
• W4320492875 cites W2055750494 @default.
• W4320492875 cites W2070880183 @default.
• W4320492875 cites W2094768566 @default.
• W4320492875 cites W2123279676 @default.
• W4320492875 cites W2129483774 @default.
• W4320492875 cites W2147158365 @default.
• W4320492875 cites W2147165437 @default.
• W4320492875 cites W2148478555 @default.
• W4320492875 cites W2151925148 @default.
• W4320492875 cites W2156966779 @default.
• W4320492875 cites W2160971157 @default.
• W4320492875 cites W2163210803 @default.
• W4320492875 cites W2166025830 @default.
• W4320492875 cites W2265628036 @default.
• W4320492875 cites W2336905440 @default.
• W4320492875 cites W2365864671 @default.
• W4320492875 cites W2516504862 @default.
• W4320492875 cites W2548724077 @default.
• W4320492875 cites W2572385011 @default.
• W4320492875 cites W2612263055 @default.
• W4320492875 cites W2735875527 @default.
• W4320492875 cites W2742938034 @default.
• W4320492875 cites W2755850037 @default.
• W4320492875 cites W2756092087 @default.
• W4320492875 cites W2793769264 @default.
• W4320492875 cites W2889378692 @default.
• W4320492875 cites W3044870380 @default.
• W4320492875 cites W3092568292 @default.
• W4320492875 cites W3118615836 @default.
• W4320492875 cites W3127468587 @default.
• W4320492875 cites W4206334326 @default.
• W4320492875 cites W4294215472 @default.
• W4320492875 cites W4296976561 @default.
• W4320492875 doi "https://doi.org/10.1093/nutrit/nuad003" @default.
• W4320492875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36779324" @default.
• W4320492875 hasPublicationYear "2023" @default.
• W4320492875 type Work @default.
• W4320492875 citedByCount "0" @default.
• W4320492875 crossrefType "journal-article" @default.
• W4320492875 hasAuthorship W4320492875A5001617413 @default.
• W4320492875 hasAuthorship W4320492875A5008553361 @default.
• W4320492875 hasAuthorship W4320492875A5015189052 @default.
• W4320492875 hasAuthorship W4320492875A5032119928 @default.
• W4320492875 hasAuthorship W4320492875A5033278584 @default.
• W4320492875 hasAuthorship W4320492875A5035828050 @default.
• W4320492875 hasAuthorship W4320492875A5049699776 @default.
• W4320492875 hasAuthorship W4320492875A5052389403 @default.
• W4320492875 hasAuthorship W4320492875A5063521556 @default.
• W4320492875 hasAuthorship W4320492875A5065377981 @default.
• W4320492875 hasAuthorship W4320492875A5077736507 @default.
• W4320492875 hasConcept C121608353 @default.
• W4320492875 hasConcept C126322002 @default.
• W4320492875 hasConcept C134018914 @default.
• W4320492875 hasConcept C151730666 @default.
• W4320492875 hasConcept C2777911890 @default.
• W4320492875 hasConcept C2779343474 @default.
• W4320492875 hasConcept C2780221984 @default.
• W4320492875 hasConcept C2780275930 @default.
• W4320492875 hasConcept C2908647359 @default.
• W4320492875 hasConcept C30092816 @default.
• W4320492875 hasConcept C530470458 @default.
• W4320492875 hasConcept C71315377 @default.
• W4320492875 hasConcept C71924100 @default.
• W4320492875 hasConcept C86803240 @default.
• W4320492875 hasConcept C99454951 @default.
• W4320492875 hasConceptScore W4320492875C121608353 @default.
• W4320492875 hasConceptScore W4320492875C126322002 @default.
• W4320492875 hasConceptScore W4320492875C134018914 @default.
• W4320492875 hasConceptScore W4320492875C151730666 @default.
• W4320492875 hasConceptScore W4320492875C2777911890 @default.
• W4320492875 hasConceptScore W4320492875C2779343474 @default.
• W4320492875 hasConceptScore W4320492875C2780221984 @default.
• W4320492875 hasConceptScore W4320492875C2780275930 @default.

• next